Should autologous HSCT be a first-line option in highly active MS: YES

Authors

Institutions

Publication Details

Journal
Multiple Sclerosis Journal
Published
2026-04-26
DOI
https://doi.org/10.1177/13524585261439669
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Should autologous HSCT be a first-line option in highly active MS: YES

Paolo Antonio Muraro, Alice Mariottini
Multiple Sclerosis Journal
Multiple Sclerosis Research Studies
article

Should autologous HSCT be a first-line option in highly active MS: YES

Paolo Antonio Muraro, Alice Mariottini
article en

Abstract

No abstract available for this paper.
Multiple Sclerosis Journal
University of Florence (IT), Imperial College London (GB)
Openalex Percentile: Top 7%
Multiple Sclerosis Research Studies
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.